| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/31/2006 | US20060194340 Also, utilization of mass spectrometry (e.g., Surface Enhanced Laser Desorption Ionization, Maldi Qq TOF, MS/MS, TOF TOF, ESI-Q-TOF or ION-TRAP) to elucidate particular indicative or predictive biopolymer markers |
| 08/31/2006 | US20060194338 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 08/31/2006 | US20060194233 Ligand of the protein "beacon" |
| 08/31/2006 | US20060193965 Oilseed processing |
| 08/31/2006 | US20060193925 such as pioglitazone, troglitazone, rosiglitazone; plant extracts of Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum in powder form; reduces body weight gain effect |
| 08/31/2006 | US20060193913 And salts such as the maleate in particulate form, prepared by wet milling; controlled release compositions |
| 08/31/2006 | US20060193871 transmission and, or amplification of signal; oral or enteric administering, dissolving, absorption; peptide yy; obesity therapy |
| 08/31/2006 | US20060193790 Promoting whole body health |
| 08/31/2006 | CA2683975A1 Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof |
| 08/31/2006 | CA2599454A1 Activator for peroxisome proliferator activating receptor d |
| 08/31/2006 | CA2598934A1 Pyridyl acetic acid compounds |
| 08/31/2006 | CA2598924A1 Use of leptin for the prevention of excess body weight and composition containing leptin |
| 08/31/2006 | CA2598869A1 Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds |
| 08/31/2006 | CA2598864A1 Promoter of regeneration of pancreatic .beta. cell, and promoter of insulin production in pancreatic .beta. cell |
| 08/31/2006 | CA2598829A1 Plant extracts and methods and uses therefore |
| 08/31/2006 | CA2598666A1 Intranasal administration of active agents to the central nervous system |
| 08/30/2006 | EP1695983A2 Glucagon-like peptide-1 analogs |
| 08/30/2006 | EP1695977A2 Spiro [isobenzofuran-1,4'piperidin]-3-ones and 3H-spiroisobenzofuran-1, 4'-piperidines |
| 08/30/2006 | EP1695975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 08/30/2006 | EP1695974A1 1,8-Naphthyridines as CRF antagonists |
| 08/30/2006 | EP1695971A1 Substituted phenyl-piperazine compounds, their preparation and use in medicaments |
| 08/30/2006 | EP1695970A1 Peptides useful for competitive modulation of dipeptidyl peptidase IV catalysis |
| 08/30/2006 | EP1695968A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 08/30/2006 | EP1695716A2 Medicinal compositions containing diuretics and insulin sensitizers |
| 08/30/2006 | EP1695706A1 Medicinal compositions and combinations |
| 08/30/2006 | EP1695705A1 Compounds effecting glucokinase |
| 08/30/2006 | EP1694673A1 Novel thiazole derivates |
| 08/30/2006 | EP1694663A1 Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 08/30/2006 | EP1694644A2 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b |
| 08/30/2006 | EP1694356A2 Regulation of food preference using glp-1 agonists |
| 08/30/2006 | EP1694355A1 Use of ghrelin and unacylated ghrelin compostions in insulin-related disease conditions |
| 08/30/2006 | EP1694354A1 Method for preventing and treating diabetes using neurturin |
| 08/30/2006 | EP1694333A2 Methods for reducing body fat using vitamin d compounds |
| 08/30/2006 | EP1660067A4 Methods and materials for treating conditions associated with metabolic disorders |
| 08/30/2006 | EP1551432B1 Argyrolobium roseum plant extracts for treating diabetes |
| 08/30/2006 | EP1513837B1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 08/30/2006 | EP1482811B1 Process for the preparation of foods comprising a probiotic delivery system |
| 08/30/2006 | EP1425280B1 Hetero-bicyclic crf antagonists |
| 08/30/2006 | EP1414810B1 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 08/30/2006 | EP1345924B1 Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| 08/30/2006 | EP1255724B1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds |
| 08/30/2006 | EP1020439B1 Cetp activity inhibitors |
| 08/30/2006 | CN1826336A Cyclohexanecarboxylic acid compound |
| 08/30/2006 | CN1826112A Compositions comprising balaglitazone and further antidiabetic compounds |
| 08/30/2006 | CN1826108A Combined use of a fibrate and orlistat for the treatment of obesity |
| 08/30/2006 | CN1824312A Compound medicine for preventing and treating cardio vascular cerebral vascular disease and its application |
| 08/30/2006 | CN1824309A Method of preparing soluble vitamin for injection using ultra sonic wave oscillation technology and its medicinal preparation |
| 08/30/2006 | CN1824293A Essential element nutritive preparation for intestine |
| 08/30/2006 | CN1824224A 'Coptis-amonum' sugar reducing compound ready prepared Chinese medicinal capsule |
| 08/30/2006 | CN1824194A Pure Chinese medicine external use body fat reducing medicine |
| 08/30/2006 | CN1824137A Sugar downbearing network vessel freeing Chinese medicinal preparation |
| 08/30/2006 | CN1824136A Preparation method of high allicin garlic powder capsule |
| 08/30/2006 | CN1824130A Medicien capable of preventing and treating cardiopathy, osteopathia, high blool pressure, diabetes etc. multi kind disease |
| 08/30/2006 | CN1824094A Health protection food possessing body fat reducing function |
| 08/30/2006 | CN1824086A Health protection capsule |
| 08/30/2006 | CN1824083A Health care function of mosailais wine and its component analysis |
| 08/30/2006 | CN1824058A Medicine and food dual purpose Chinese medicinal product for preventing and treating nightblindness and its manufacturing method |
| 08/30/2006 | CN1823981A New preparation for treating obesity |
| 08/30/2006 | CN1823964A Method of raising insulin excretion by capejasmine extract through specificity inhibition UCP2 |
| 08/30/2006 | CN1823959A Heart vessel free flowing dispersion tablet and its preparation method |
| 08/30/2006 | CN1823922A Medicinal composition containing borneol |
| 08/30/2006 | CN1823881A Medicine for treating diabetes and its preparation method |
| 08/30/2006 | CN1823880A Preparation method of medicine or food for thinning reducing fat |
| 08/30/2006 | CN1823849A Extract of ferric trichloride and algae |
| 08/30/2006 | CN1823845A Oral medicine containing zinc selenium calcium and its manufacturing method |
| 08/30/2006 | CN1823829A Vitamin micro element mineral calcium nutritive product for preventing pseudomyopia and roal myopia and its manufacturing method |
| 08/30/2006 | CN1823817A Electrolyte nutrition fortification agent |
| 08/30/2006 | CN1823811A Application of physalis alkekengi polysaccharide in preparation of medicine and health care product for treating diabetes |
| 08/30/2006 | CN1823809A Preservative less water soluble vitamin preparation for injection and its formulating method |
| 08/30/2006 | CN1823795A Medicinal composition for treating diabetes and its preparation method |
| 08/30/2006 | CN1823792A New liver beneficial capsule and its preparation method |
| 08/30/2006 | CN1823786A Sterilization technology of prostadil fatty emulsion and method of determination |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823779A Ruishufatatinggan soft capsule and its preparation method |
| 08/30/2006 | CN1823758A Compounds and methods of treating transplant rejection |
| 08/30/2006 | CN1823755A Nateglinide soft capsule and its preparation method |
| 08/30/2006 | CN1823750A Sibuqumin hydrochloride drip pill |
| 08/30/2006 | CN1823744A Colloidal suspension of submicronic particles as vectors for active principles and method for preparing same |
| 08/30/2006 | CN1823632A Method of eating total tortoise and soft shelled turtle and preparation technology of complete tonic tortoise and soft shelled turtle pill (powder) |
| 08/30/2006 | CN1823604A Seaweed tea and its preparation method |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272069C Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue |
| 08/30/2006 | CN1272068C Oyster natural active peptide and its preparation method and its application in the preparation of anticancer medicine |
| 08/30/2006 | CN1272054C Medicine for treating diabetes and its preparing process |
| 08/30/2006 | CN1272048C Medicine capsule for treating diabetes |
| 08/30/2006 | CN1272033C Blood fat reducing tablet and its preparation |
| 08/30/2006 | CN1272025C Solid fermented fungus powder for use in medicine |
| 08/30/2006 | CN1272023C Cod-liver oil, royal jelly freeze-dry powder capsule and its process |
| 08/30/2006 | CN1272011C Phytosterol and/or plant steroid alkanol derivative |
| 08/30/2006 | CN1272004C Use of Chinese medicinal palmatine hydrochloride in treatment of diabetes II |
| 08/30/2006 | CN1271947C Preparation method of edible nutritious health powder for diabetes patients |
| 08/29/2006 | US7098375 Animal and cell models for type II diabetes and their use |
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098336 FXR NR1H4 nuclear receptor binding compounds |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098246 Esterified hydroxytyrosol; 2-(3,4-dihydroxyphenyl)ethyl acetate for example |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098230 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/29/2006 | US7098229 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |